Skip to main content
. 2017 Sep 11;372(1732):20160275. doi: 10.1098/rstb.2016.0275

Figure 2.

Figure 2.

Schematic of KSHV-promoted activation of STAT3, PI3 K/Akt, MAPK and PLCγ/NFAT pathways contributing to proliferation and migration of KSHV-infected endothelial cells. The transmembrane viral proteins vGPCR, K1 and K15 as well as the viral IL6 homologue vIL6, kaposin B and ORF36 activate PLCγ, Akt, MAPK and STAT3 pathways. Some of these could be promising targets to inhibit the development of Kaposi's sarcoma.